Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
    41.
    发明申请
    Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors 失效
    用作PDE4抑制剂的取代的2-喹啉基 - 恶唑

    公开(公告)号:US20060106062A1

    公开(公告)日:2006-05-18

    申请号:US11130359

    申请日:2005-05-16

    摘要: The invention claims compounds of the formula wherein is a 5-membered heteroaryl; X is S or O; R1 is H, alkyl, cycloalkyl, cylcoalkylalkyl-, —CH2F, —CHF2, —CF3, —C(O)alkyl or —C(O)NR18R19; R3 and R4H, alkyl, hydroxyalkyl or —C(O)Oalkyl; R5 and R6 are H, alkyl, hydroxyalkyl, alkoxyalkyl, mercaptoalkyl, —CH2F, —CHF2, —CF3, —C(O)OH or —C(O)Oalkyl; R7 is H, alkyl, alkenyl, hydroxyalkyl, cycloalkyl, alkoxyalkyl, aminoalkyl, (R17-phenyl)alkyl or —CH2—C(O)—O-alkyl; and R8 comprises alkyl, heteroaryl, phenyl or cycloalkyl, or heterocycloalkyl, all optionally substituted, or a cycloalkyl- or heterocycloalkyl-substituted amide; or R7 and R8 and the nitrogen to which they are attached together form an optionally substituted ring; and the remaining variables are as defined in the specification. Also claimed are pharmaceutical compositions, the use of the compounds as PDE4 inhibitors, and combinations with other actives.

    摘要翻译: 本发明要求具有下式的化合物其中是5元杂芳基; X是S或O; R 1是H,烷基,环烷基,环烷基烷基 - ,-CH 2 F,-CHF 2,-CF 3, -C(O)烷基或-C(O)NR 18 R 19; R 3和R 4 H,烷基,羟烷基或-C(O)O烷基; R 5和R 6是H,烷基,羟基烷基,烷氧基烷基,巯基烷基,-CH 2 F 2,-CHF 2, -CF 3,-C(O)OH或-C(O)O烷基; R 7是H,烷基,烯基,羟基烷基,环烷基,烷氧基烷基,氨基烷基,(R 17 - 苯基)烷基或-CH 2 - C(O)-O-烷基; 和R 8包括烷基,杂芳基,苯基或环烷基,或杂环烷基,全部被取代,或环烷基 - 或杂环烷基取代的酰胺; 或R 7和R 8和它们所连接的氮一起形成任选取代的环; 其余变量如本说明书中所定义。 还要求保护的是药物组合物,化合物作为PDE4抑制剂的用途,以及与其它活性物质的组合。

    Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
    46.
    发明授权
    Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors 失效
    用作PDE4抑制剂的取代的2-喹啉基 - 恶唑

    公开(公告)号:US07511062B2

    公开(公告)日:2009-03-31

    申请号:US11130359

    申请日:2005-05-16

    IPC分类号: C07D215/38 A61K31/44

    摘要: The invention claims compounds of the formula wherein is a 5-membered heteroaryl; X is S or O; R1 is H, alkyl, cycloalkyl, cylcoalkylalkyl-, —CH2F, —CHF2, —CF3, —C(O)alkyl or —C(O)NR18R19; R3 and R4 H, alkyl, hydroxyalkyl or —C(O)Oalkyl; R5 and R6 are H, alkyl, hydroxyalkyl, alkoxyalkyl, mercaptoalkyl, —CH2F, —CHF2, —CF3, —C(O)OH or —C(O)Oalkyl; R7 is H, alkyl, alkenyl, hydroxyalkyl, cycloalkyl, alkoxyalkyl, aminoalkyl, (R17-phenyl)alkyl or —CH2—C(O)—O-alkyl; and R8 comprises alkyl, heteroaryl, phenyl or cycloalkyl, or heterocycloalkyl, all optionally substituted, or a cycloalkyl- or heterocycloalkyl-substituted amide; or R7 and R8 and the nitrogen to which they are attached together form an optionally substituted ring; and the remaining variables are as defined in the specification. Also claimed are pharmaceutical compositions, the use of the compounds as PDE4 inhibitors, and combinations with other actives.

    摘要翻译: 本发明要求具有下式的化合物其中是5元杂芳基; X是S或O; R 1是H,烷基,环烷基,环烷基烷基 - , - CH 2 F,-CHF 2,-CF 3,-C(O)烷基或-C(O)NR 18 R 19; R 3和R 4 H,烷基,羟基烷基或-C(O)O烷基; R5和R6是H,烷基,羟基烷基,烷氧基烷基,巯基烷基,-CH2F,-CHF2,-CF3,-C(O)OH或-C(O) R 7是H,烷基,烯基,羟基烷基,环烷基,烷氧基烷基,氨基烷基,(R 17 - 苯基)烷基或-CH 2 -C(O)-O-烷基; 和R8包括烷基,杂芳基,苯基或环烷基,或杂环烷基,全部任意取代,或环烷基 - 或杂环烷基取代的酰胺; 或R 7和R 8,并且与它们相连的氮一起形成任选取代的环; 其余变量如本说明书中所定义。 还要求保护的是药物组合物,化合物作为PDE4抑制剂的用途,以及与其它活性物质的组合。